BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 15710860)

  • 1. A novel intronic mutation in the DDP1 gene in a family with X-linked dystonia-deafness syndrome.
    Ezquerra M; Campdelacreu J; Muñoz E; Tolosa E; Martí MJ
    Arch Neurol; 2005 Feb; 62(2):306-8. PubMed ID: 15710860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Spanish sporadic case of deafness-dystonia (Mohr-Tranebjaerg) syndrome with a novel mutation in the gene encoding TIMM8a, a component of the mitochondrial protein translocase complexes.
    Aguirre LA; Pérez-Bas M; Villamar M; López-Ariztegui MA; Moreno-Pelayo MA; Moreno F; del Castillo I
    Neuromuscul Disord; 2008 Dec; 18(12):979-81. PubMed ID: 18952432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and molecular findings in a patient with a novel mutation in the deafness-dystonia peptide (DDP1) gene.
    Binder J; Hofmann S; Kreisel S; Wöhrle JC; Bäzner H; Krauss JK; Hennerici MG; Bauer MF
    Brain; 2003 Aug; 126(Pt 8):1814-20. PubMed ID: 12805099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blepharospasm and limb dystonia caused by Mohr-Tranebjaerg syndrome with a novel splice-site mutation in the deafness/dystonia peptide gene.
    Kim HT; Edwards MJ; Tyson J; Quinn NP; Bitner-Glindzicz M; Bhatia KP
    Mov Disord; 2007 Jul; 22(9):1328-31. PubMed ID: 17534980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dystonia in the Mohr-Tranebjaerg syndrome responds to GABAergic substances.
    Kreisel SH; Binder J; Wöhrle JC; Krauss JK; Hofmann S; Bauer MF; Hennerici MG; Bäzner H
    Mov Disord; 2004 Oct; 19(10):1241-3. PubMed ID: 15390009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel X-linked gene, DDP, shows mutations in families with deafness (DFN-1), dystonia, mental deficiency and blindness.
    Jin H; May M; Tranebjaerg L; Kendall E; Fontán G; Jackson J; Subramony SH; Arena F; Lubs H; Smith S; Stevenson R; Schwartz C; Vetrie D
    Nat Genet; 1996 Oct; 14(2):177-80. PubMed ID: 8841189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel intragenic FRMD7 deletion in a pedigree with congenital X-linked nystagmus.
    Fingert JH; Roos B; Eyestone ME; Pham JD; Mellot ML; Stone E
    Ophthalmic Genet; 2010 Jun; 31(2):77-80. PubMed ID: 20450309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of mutations in the COL4A5 gene by SSCP in X-linked Alport syndrome.
    Hertz JM; Juncker I; Persson U; Matthijs G; Schmidtke J; Petersen MB; Kjeldsen M; Gregersen N
    Hum Mutat; 2001 Aug; 18(2):141-8. PubMed ID: 11462238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in expression levels of deafness dystonia protein 1 affect mitochondrial morphology.
    Engl G; Florian S; Tranebjærg L; Rapaport D
    Hum Mol Genet; 2012 Jan; 21(2):287-99. PubMed ID: 21984432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. X-linked adrenal hypoplasia congenita caused by a novel intronic mutation of the DAX-1 gene.
    Goto M; Katsumata N
    Horm Res; 2009; 71(2):120-4. PubMed ID: 19129717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel CACNA1F gene mutation causes Aland Island eye disease.
    Jalkanen R; Bech-Hansen NT; Tobias R; Sankila EM; Mäntyjärvi M; Forsius H; de la Chapelle A; Alitalo T
    Invest Ophthalmol Vis Sci; 2007 Jun; 48(6):2498-502. PubMed ID: 17525176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A de novo missense mutation in a critical domain of the X-linked DDP gene causes the typical deafness-dystonia-optic atrophy syndrome.
    Tranebjaerg L; Hamel BC; Gabreels FJ; Renier WO; Van Ghelue M
    Eur J Hum Genet; 2000 Jun; 8(6):464-7. PubMed ID: 10878669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dystonia with and without deafness is caused by TIMM8A mutation.
    Swerdlow RH; Juel VC; Wooten GF
    Adv Neurol; 2004; 94():147-54. PubMed ID: 14509668
    [No Abstract]   [Full Text] [Related]  

  • 15. Distinct Clinical Features and Novel Mutations in Taiwanese Patients With X-Linked Agammaglobulinemia.
    Yeh YH; Hsieh MY; Lee WI; Huang JL; Chen LC; Yeh KW; Ou LS; Yao TC; Wu CY; Lin SJ
    Front Immunol; 2020; 11():2001. PubMed ID: 33013854
    [No Abstract]   [Full Text] [Related]  

  • 16. A novel insertion mutation in the SEDL gene results in X-linked spondyloepiphyseal dysplasia tarda in a large Chinese pedigree.
    Xia XY; Cui YX; Zhou YC; Zhou X; Shi YC; Wei L; Li XJ; Huang YF; Huang TT
    Clin Chim Acta; 2009 Dec; 410(1-2):39-42. PubMed ID: 19766614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel RPGR gene mutation in a Chinese family with X-linked dominant retinitis pigmentosa.
    Li Y; Dong B; Hu AL; Cui TT; Zheng YY
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Aug; 22(4):396-8. PubMed ID: 16086276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of an intronic single-point mutation in RP2 as the cause of semidominant X-linked retinitis pigmentosa.
    Pomares E; Riera M; Castro-Navarro J; Andrés-Gutiérrez A; Gonzàlez-Duarte R; Marfany G
    Invest Ophthalmol Vis Sci; 2009 Nov; 50(11):5107-14. PubMed ID: 19516003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular genetics of a patient with Mohr-Tranebjaerg Syndrome due to a new mutation in the DDP1 gene.
    Blesa JR; Solano A; Briones P; Prieto-Ruiz JA; Hernández-Yago J; Coria F
    Neuromolecular Med; 2007; 9(4):285-91. PubMed ID: 17999202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and molecular characterizations of novel POU3F4 mutations reveal that DFN3 is due to null function of POU3F4 protein.
    Lee HK; Song MH; Kang M; Lee JT; Kong KA; Choi SJ; Lee KY; Venselaar H; Vriend G; Lee WS; Park HJ; Kwon TK; Bok J; Kim UK
    Physiol Genomics; 2009 Nov; 39(3):195-201. PubMed ID: 19671658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.